Literature DB >> 28236635

The competing endogenous RNA network of CYP4Z1 and pseudogene CYP4Z2P exerts an anti-apoptotic function in breast cancer.

Cheng Li1,2, Lufeng Zheng1,2, Yu Xin1,2, Zhoulin Tan1,2, Yan Zhang1,2, Xia Meng1,2, Zhigang Wang3, Tao Xi1,2.   

Abstract

The competing endogenous RNA network (ceRNET) is involved in tumorigenesis and has become a hot spot of research. The ceRNET between CYP4Z1 and the pseudogene CYP4Z2P promotes angiogenesis and mediates tamoxifen resistance in breast cancer. Nevertheless, the effects of this ceRNET on cell apoptosis and related mechanisms remain unclear. In the present study, we found that downregulation of CYP4Z1 or the CYP4Z2P 3'-UTR promotes cell apoptosis, mirroring the functions of human telomerase reverse transcriptase (hTERT). Furthermore, the ceRNET between CYP4Z1 and pseudogene CYP4Z2P modulates hTERT expression by operating as a sub-ceRNET for hTERT. Our data demonstrate that the ceRNET between CYP4Z1 and pseudogene CYP4Z2P acts as a sub-ceRNET for hTERT and, thus, inhibits breast cancer apoptosis.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990hTERTzzm321990; CYP4Z1; CYP4Z2P; apoptosis; ceRNET

Mesh:

Substances:

Year:  2017        PMID: 28236635     DOI: 10.1002/1873-3468.12608

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Assessment of Phenylboronic Acid Nitrogen Mustards as Potent and Selective Drug Candidates for Triple-Negative Breast Cancer.

Authors:  Heli Fan; Muhammad Asad Uz Zaman; Wenbing Chen; Taufeeque Ali; Anahit Campbell; Qi Zhang; Nurul Islam Setu; Eron Saxon; Nicolas M Zahn; Anna M Benko; Leggy A Arnold; Xiaohua Peng
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-07

Review 2.  Noncoding RNA:RNA Regulatory Networks in Cancer.

Authors:  Jia Jia Chan; Yvonne Tay
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

3.  STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.

Authors:  Lufeng Zheng; Chenxi Xiang; Xiaoman Li; Qianqian Guo; Lanlan Gao; Haiwei Ni; Yufeng Xia; Tao Xi
Journal:  J Hematol Oncol       Date:  2018-05-30       Impact factor: 17.388

4.  Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis.

Authors:  Xiujuan Zhang; Xiaole Song; Yuting Lai; Bijun Zhu; Jiqin Luo; Hongmeng Yu; Yiqun Yu
Journal:  BMC Cancer       Date:  2021-04-30       Impact factor: 4.430

Review 5.  Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies.

Authors:  Smarakan Sneha; Simon C Baker; Andrew Green; Sarah Storr; Radhika Aiyappa; Stewart Martin; Klaus Pors
Journal:  Biomedicines       Date:  2021-03-12

6.  Cancerin: A computational pipeline to infer cancer-associated ceRNA interaction networks.

Authors:  Duc Do; Serdar Bozdag
Journal:  PLoS Comput Biol       Date:  2018-07-16       Impact factor: 4.475

Review 7.  Role of Pseudogenes in Tumorigenesis.

Authors:  Xinling Hu; Liu Yang; Yin-Yuan Mo
Journal:  Cancers (Basel)       Date:  2018-08-01       Impact factor: 6.639

8.  Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.

Authors:  Lufeng Zheng; Qianqian Guo; Chenxi Xiang; Shijia Liu; Yuzhang Jiang; Lanlan Gao; Haiwei Ni; Ting Wang; Qiong Zhao; Hai Liu; Yingying Xing; Yaohui Wang; Xiaoman Li; Tao Xi
Journal:  J Hematol Oncol       Date:  2019-03-04       Impact factor: 17.388

Review 9.  Re-recognition of pseudogenes: From molecular to clinical applications.

Authors:  Xu Chen; Lin Wan; Wei Wang; Wen-Jin Xi; An-Gang Yang; Tao Wang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 10.  Roles of ncRNAs as ceRNAs in Gastric Cancer.

Authors:  Junhong Ye; Jifu Li; Ping Zhao
Journal:  Genes (Basel)       Date:  2021-07-02       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.